Joseph Yanai

Last updated
Joseph Yanai Portrait.png

Joseph Yanai is a researcher pioneering in studying the reversal of neurobehavioral birth defects in animal models. [1] He serves as a professor and Director of the Ross Laboratory for Studies in Neural Birth Defects at the Department of Medical Neurobiology, The Institute For Medical Research, Israel-Canada (IMRIC) at the Hebrew University-Hadassah Medical School Jerusalem, Israel and was also appointed as Adjunct Professor, Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA.

Contents

Education

Yanai was born in Rehovot, Israel in 1944. After graduating from the Mikveh Israel Agricultural High School, he received his BSc Agr. in agriculture and genetics at the Hebrew University of Jerusalem in 1967; both his MA in 1970 and PhD in 1971 from the University of Colorado Boulder

Professional career

Research work

Since 1973, he has been among the forerunners in the study of behavioral birth defects. [3] His novel approach was to study the mechanism by which certain neuroteratogens induce their deleterious effect, focusing on behavioral defects that are mechanistically related to septohippocampal cholinergic innervation. [4] The results showed alterations in cholinergic neurotransmission cascade converging into the abolishment of the cholinergic receptor-induced activation/translocation PKC activity. [5] By ascertaining the mechanisms of the neuroteratogenicity, he pointed in his book “neurobehavioral teratology.” [6] to the future of the field by establishing the concept of "Neurobehavioral teratology. Furthermore, Yanai argued that understanding the mechanism of the developmental defect will eventually enable its reversal, a concept that seemed like science fiction in 1984.

Specifically since 1987, Yanai has developed animal models for the reversal of neurobehavioral birth defects, starting with manipulation of A10 septal dopaminergic innervation, [7] nicotine therapy, [8] but most significantly, by transplantation of cells to the impaired brain. These included fetal differentiated brain cells (neural grafting), [9] and in subsequent studies, stem cells of various origins: embryonic, neural stem cells, [10] subventricular stem cells, [11] and mesenchymal stem cells. [12] [13] Transplantation of cells of all types reversed the prenatally-induced behavioral deficits and the mechanistically related neural alterations. Further studies suggested that one major mechanism by which the stem cells exert their therapeutic action is by enhancing neurogenesis. [14] [15]

These findings were published in the leading journal (for example Molecular Psychiatry , [16] ) and received an widespread media attention (external links [17] [18] ) and presented in an invited major address, at the  international conferences in San Antonio, Texas, in June 2016. [19] Review of Yanai’s work and the progress in reversal of neurobehavioral teratology that was advanced by other laboratories was published in 2019 [20] and in Basel, Switzerland in February 2017.

Related Research Articles

<span class="mw-page-title-main">Stem cell</span> Undifferentiated biological cells that can differentiate into specialized cells

In multicellular organisms, stem cells are undifferentiated or partially differentiated cells that can differentiate into various types of cells and proliferate indefinitely to produce more of the same stem cell. They are the earliest type of cell in a cell lineage. They are found in both embryonic and adult organisms, but they have slightly different properties in each. They are usually distinguished from progenitor cells, which cannot divide indefinitely, and precursor or blast cells, which are usually committed to differentiating into one cell type.

Teratology is the study of abnormalities of physiological development in organisms during their life span. It is a sub-discipline in medical genetics which focuses on the classification of congenital abnormalities in dysmorphology caused by teratogens. Teratogens are substances that may cause non-heritable birth defects via a toxic effect on an embryo or fetus. Defects include malformations, disruptions, deformations, and dysplasia that may cause stunted growth, delayed mental development, or other congenital disorders that lack structural malformations. The related term developmental toxicity includes all manifestations of abnormal development that are caused by environmental insult. The extent to which teratogens will impact an embryo is dependent on several factors, such as how long the embryo has been exposed, the stage of development the embryo was in when exposed, the genetic makeup of the embryo, and the transfer rate of the teratogen.

<span class="mw-page-title-main">Anencephaly</span> Neural tube defect involving absence of much of the brain, skull and scalp

Anencephaly is the absence of a major portion of the brain, skull, and scalp that occurs during embryonic development. It is a cephalic disorder that results from a neural tube defect that occurs when the rostral (head) end of the neural tube fails to close, usually between the 23rd and 26th day following conception. Strictly speaking, the Greek term translates as "without a brain", but it is accepted that children born with this disorder usually only lack a telencephalon, the largest part of the brain consisting mainly of the cerebral hemispheres, including the neocortex, which is responsible for cognition. The remaining structure is usually covered only by a thin layer of membrane—skin, bone, meninges, etc., are all lacking. With very few exceptions, infants with this disorder do not survive longer than a few hours or days after birth.

<span class="mw-page-title-main">Severe combined immunodeficiency</span> Genetic disorder leading to severe impairment of the immune system

Severe combined immunodeficiency (SCID), also known as Swiss-type agammaglobulinemia, is a rare genetic disorder characterized by the disturbed development of functional T cells and B cells caused by numerous genetic mutations that result in differing clinical presentations. SCID involves defective antibody response due to either direct involvement with B lymphocytes or through improper B lymphocyte activation due to non-functional T-helper cells. Consequently, both "arms" of the adaptive immune system are impaired due to a defect in one of several possible genes. SCID is the most severe form of primary immunodeficiencies, and there are now at least nine different known genes in which mutations lead to a form of SCID. It is also known as the bubble boy disease and bubble baby disease because its victims are extremely vulnerable to infectious diseases and some of them, such as David Vetter, have become famous for living in a sterile environment. SCID is the result of an immune system so highly compromised that it is considered almost absent.

<span class="mw-page-title-main">Birth defect</span> Condition present at birth regardless of cause; human disease or disorder developed prior to birth

A birth defect, also known as a congenital disorder, is an abnormal condition that is present at birth regardless of its cause. Birth defects may result in disabilities that may be physical, intellectual, or developmental. The disabilities can range from mild to severe. Birth defects are divided into two main types: structural disorders in which problems are seen with the shape of a body part and functional disorders in which problems exist with how a body part works. Functional disorders include metabolic and degenerative disorders. Some birth defects include both structural and functional disorders.

<span class="mw-page-title-main">Cholinergic</span> Agent which mimics choline

Cholinergic agents are compounds which mimic the action of acetylcholine and/or butyrylcholine. In general, the word "choline" describes the various quaternary ammonium salts containing the N,N,N-trimethylethanolammonium cation. Found in most animal tissues, choline is a primary component of the neurotransmitter acetylcholine and functions with inositol as a basic constituent of lecithin. Choline also prevents fat deposits in the liver and facilitates the movement of fats into cells.

<span class="mw-page-title-main">Adult neurogenesis</span> Generating of neurons from neural stem cells in adults

Adult neurogenesis is the process in which neurons are generated from neural stem cells in the adult. This process differs from prenatal neurogenesis.

<span class="mw-page-title-main">Adult stem cell</span> Multipotent stem cell in the adult body

Adult stem cells are undifferentiated cells, found throughout the body after development, that multiply by cell division to replenish dying cells and regenerate damaged tissues. Also known as somatic stem cells, they can be found in juvenile, adult animals, and humans, unlike embryonic stem cells.

<span class="mw-page-title-main">Neural tube defect</span> Group of birth defects of the brain or spinal cord

Neural tube defects (NTDs) are a group of birth defects in which an opening in the spine or cranium remains from early in human development. In the third week of pregnancy called gastrulation, specialized cells on the dorsal side of the embryo begin to change shape and form the neural tube. When the neural tube does not close completely, an NTD develops.

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. As of 2016, the only established therapy using stem cells is hematopoietic stem cell transplantation. This usually takes the form of a bone-marrow transplantation, but the cells can also be derived from umbilical cord blood. Research is underway to develop various sources for stem cells as well as to apply stem-cell treatments for neurodegenerative diseases and conditions such as diabetes and heart disease.

Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons. Neuromodulators typically bind to metabotropic, G-protein coupled receptors (GPCRs) to initiate a second messenger signaling cascade that induces a broad, long-lasting signal. This modulation can last for hundreds of milliseconds to several minutes. Some of the effects of neuromodulators include: altering intrinsic firing activity, increasing or decreasing voltage-dependent currents, altering synaptic efficacy, increasing bursting activity and reconfigurating synaptic connectivity.

Neural stem cells (NSCs) are self-renewing, multipotent cells that firstly generate the radial glial progenitor cells that generate the neurons and glia of the nervous system of all animals during embryonic development. Some neural progenitor stem cells persist in highly restricted regions in the adult vertebrate brain and continue to produce neurons throughout life. Differences in the size of the central nervous system are among the most important distinctions between the species and thus mutations in the genes that regulate the size of the neural stem cell compartment are among the most important drivers of vertebrate evolution.

An amniotic epithelial cell is a form of stem cell extracted from the lining of the inner membrane of the placenta. Amniotic epithelial cells start to develop around 8 days post fertilization. These cells are known to have some of the same markers as embryonic stem cells, more specifically, Oct-4 and nanog. These transcription factors are the basis of the pluripotency of stem cells. Amniotic epithelial cells have the ability to develop into any of the three germ layers: endoderm, mesoderm, and ectoderm. They can develop into several organ tissues specific to these germ layers including heart, brain, and liver. The pluripotency of the human amniotic epithelial cells makes them useful in treating and fighting diseases and disorders of the nervous system as well as other tissues of the human body. Artificial heart valves and working tracheas, as well as muscle, fat, bone, heart, neural and liver cells have all been engineered using amniotic stem cells. Tissues obtained from amniotic cell lines show promise for patients with congenital diseases or malformations of the heart, liver, lungs, kidneys, and cerebral tissue.

Neural tissue engineering is a specific sub-field of tissue engineering. Neural tissue engineering is primarily a search for strategies to eliminate inflammation and fibrosis upon implantation of foreign substances. Often foreign substances in the form of grafts and scaffolds are implanted to promote nerve regeneration and to repair damage caused to nerves of both the central nervous system (CNS) and peripheral nervous system (PNS) by an injury.

Nervous system diseases, also known as nervous system or neurological disorders, refers to a small class of medical conditions affecting the nervous system. This category encompasses over 600 different conditions, including genetic disorders, infections, cancer, seizure disorders, conditions with a cardiovascular origin, congenital and developmental disorders, and degenerative disorders.

<span class="mw-page-title-main">Fibrochondrogenesis</span> Medical condition

Fibrochondrogenesis is a rare autosomal recessive form of osteochondrodysplasia, causing abnormal fibrous development of cartilage and related tissues.

<span class="mw-page-title-main">Cerebral organoid</span> Artificial miniature brain like organ

A cerebral organoid, or brain organoid, describes an artificially grown, in vitro, miniature organ resembling the brain. Cerebral organoids are created by culturing pluripotent stem cells in a three-dimensional rotational bioreactor, and they develop over a course of months. The brain is an extremely complex system of heterogeneous tissues and consists of a diverse array of neurons. This complexity has made studying the brain and understanding how it works a difficult task in neuroscience, especially when it comes to neurodegenerative diseases. The purpose of creating an in vitro neurological model is to study these diseases in a more simple and variable space. This 3D model is free of many potential in vivo limitations. The varying physiology between human and other mammalian models limits the scope of study in neurological disorders. Cerebral organoids are synthesized tissues that contain several types of nerve cells and have anatomical features that recapitulate regions of the cortex observed in brains. Cerebral organoids are most similar to layers of neurons called the cortex and choroid plexus. In some cases, structures similar to the retina, meninges and hippocampus can form. Stem cells have the potential to grow into many different types of tissues, and their fate is dependent on many factors. Below is an image showing some of the chemical factors that can lead stem cells to differentiate into various neural tissues; a more in-depth table of generating specific organoid identity has been published since. Similar techniques are used on stem cells used to grow cerebral organoids.

<span class="mw-page-title-main">Cholinergic neuron</span> Type of nerve cell

A cholinergic neuron is a nerve cell which mainly uses the neurotransmitter acetylcholine (ACh) to send its messages. Many neurological systems are cholinergic. Cholinergic neurons provide the primary source of acetylcholine to the cerebral cortex, and promote cortical activation during both wakefulness and rapid eye movement sleep. The cholinergic system of neurons has been a main focus of research in aging and neural degradation, specifically as it relates to Alzheimer's disease. The dysfunction and loss of basal forebrain cholinergic neurons and their cortical projections are among the earliest pathological events in Alzheimer's disease.

<span class="mw-page-title-main">Cell-based therapies for Parkinson's disease</span> Treatment method for Parkinsons disease

Cell-based therapies for Parkinson's disease include various investigational procedures which transplant specific populations of cells into the brains of people with Parkinson's disease. The investigation of cell transplantation therapies followed the discovery that the death of dopaminergic neurons in the substantia nigra pars compacta resulted in the motor symptoms of the disease. Thus, cell transplantation has focused on various dopamine producing cells throughout the body.

Shiverer mice are mice which possess the shiverer (shi/shi) mutation in the MBP gene. Shiverer mice develop a characteristic "shaking" or "shivering" gait within a few weeks of birth. They are commonly used as animal models of leukodystrophy in neuroscience research.

References

  1. Yanai, Joseph; Vigoda, Myles J.; Ornoy, Asher (August 2019). "Reversal of neurobehavioral teratogenicity in animal models and human: Three decades of progress". Brain Research Bulletin. 150: 328–342. doi:10.1016/j.brainresbull.2019.06.009. ISSN   0361-9230. PMID   31207281. S2CID   189820103.
  2. "Professor Joseph Yanai". The Hebrew University of Jerusalem.
  3. "Behavior genetics association abstracts". Behavior Genetics. 3 (4): 393–419. December 1973. doi:10.1007/bf01070223. ISSN   0001-8244. S2CID   189854750.
  4. "Behavior genetics association abstracts". Behavior Genetics. 3 (4): 393–419. December 1973. doi:10.1007/bf01070223. ISSN   0001-8244. S2CID   189854750.
  5. Yanai, Joseph; Beer, Avital; Huleihel, Rabab; Izrael, Michal; Katz, Sofia; Levi, Yaarit; Rozenboim, Israel; Yaniv, Shiri P.; Slotkin, Theodore A. (October 2004). "Convergent Effects on Cell Signaling Mechanisms Mediate the Actions of Different Neurobehavioral Teratogens: Alterations in Cholinergic Regulation of Protein Kinase C in Chick and Avian Models". Annals of the New York Academy of Sciences. 1025 (1): 595–601. doi:10.1196/annals.1316.074. ISSN   0077-8923. PMID   15542768. S2CID   10927050.
  6. Neurobehavioral teratology. Joseph Yanai. Amsterdam: Elsevier. 1984. ISBN   0-444-80516-8. OCLC   10275574.{{cite book}}: CS1 maint: others (link)
  7. Yanai, Joseph; Laxer, Uri; Pick, Chaim G.; Trombka, David (August 1989). "Dopaminergic denervation reverses behavioral deficits induced by prenatal exposure to phenobarbital". Developmental Brain Research. 48 (2): 255–261. doi:10.1016/0165-3806(89)90080-1. ISSN   0165-3806. PMID   2505945.
  8. Beer, Avital; Slotkin, Theodore A; Seidler, Frederic J; Aldridge, Justin E; Yanai, Joseph (2004-10-20). "Nicotine Therapy in Adulthood Reverses the Synaptic and Behavioral Deficits Elicited by Prenatal Exposure to Phenobarbital". Neuropsychopharmacology. 30 (1): 156–165. doi: 10.1038/sj.npp.1300582 . ISSN   0893-133X. PMID   15496940.
  9. Yanai, Joseph; Pick, Chaim G. (1988). "Neuron transplantation reverses phenobarbital-induced behavioral birth defects in mice". International Journal of Developmental Neuroscience. 6 (5): 409–416. doi:10.1016/0736-5748(88)90046-9. ISSN   0736-5748. PMID   3202000. S2CID   23370083.
  10. Kazma, Meital; Izrael, Michal; Revel, Michel; Chebath, Judith; Yanai, Joseph (2010-02-01). "Survival, differentiation, and reversal of heroin neurobehavioral teratogenicity in mice by transplanted neural stem cells derived from embryonic stem cells". Journal of Neuroscience Research. 88 (2): 315–323. doi:10.1002/jnr.22193. ISSN   0360-4012. PMID   19746435. S2CID   24682086.
  11. Turgeman, Gadi; Pinkas, Adi; Slotkin, Theodore A.; Tfilin, Matanel; Langford, Rachel; Yanai, Joseph (2011-04-21). "Reversal of chlorpyrifos neurobehavioral teratogenicity in mice by allographic transplantation of adult subventricular zone-derived neural stem cells". Journal of Neuroscience Research. 89 (8): 1185–1193. doi:10.1002/jnr.22631. ISSN   0360-4012. PMID   21520219. S2CID   3424029.
  12. Yanai, Joseph; Vigoda, Myles J.; Ornoy, Asher (August 2019). "Reversal of neurobehavioral teratogenicity in animal models and human: Three decades of progress". Brain Research Bulletin. 150: 328–342. doi:10.1016/j.brainresbull.2019.06.009. ISSN   0361-9230. PMID   31207281. S2CID   189820103.
  13. "Stem cell therapy may reverse brain birth defects". Oneindia.com. 30 December 2008.
  14. "Health Scan: Stem cell therapy may reverse brain defects". The Jerusalem Post.
  15. Ben-Shaanan, T L; Ben-Hur, T; Yanai, J (2007-09-18). "Transplantation of neural progenitors enhances production of endogenous cells in the impaired brain". Molecular Psychiatry. 13 (2): 222–231. doi: 10.1038/sj.mp.4002084 . ISSN   1359-4184. PMID   17876325. S2CID   12784221.
  16. Ben-Shaanan, TL, Ben-Hur, T, and Yanai, J.: “Transplantation of neural progenitors enhances production of endogeneous cells in the impaired brain”. Molecular Psychiatry, September 18, 2007. Vol. 13, No. 2, pp222-231
  17. "Hebrew University Scientists Succeed Through Stem Cell Therapy in Reversing Brain Birth Defects". Technology Networks.
  18. "Stem Cells Undo Birth Defects". MIT Technology Review.
  19. Yanai, Joseph (May 2016). "Fortieth Anniversary Annual Meeting of the Developmental Neurotoxicology Society Held in Conjunction with the 56th Annual Meeting of the Teratology Society Grand Hyatt San Antonio, San Antonio, Texas June 25–29, 2016". Neurotoxicology and Teratology. 55: 58–75. doi:10.1016/j.ntt.2016.04.003. ISSN   0892-0362.
  20. Yanai, Joseph; Vigoda, Myles J.; Ornoy, Asher (August 2019). "Reversal of neurobehavioral teratogenicity in animal models and human: Three decades of progress". Brain Research Bulletin. 150: 328–342. doi:10.1016/j.brainresbull.2019.06.009. ISSN   0361-9230. PMID   31207281. S2CID   189820103.